Integrated Stent Delivery System: A Next Generation of Stent Delivery and Drug-Eluting Stent.


Journal

Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551

Informations de publication

Date de publication:
02 2020
Historique:
received: 29 10 2018
revised: 29 03 2019
accepted: 10 04 2019
pubmed: 19 5 2019
medline: 23 9 2020
entrez: 19 5 2019
Statut: ppublish

Résumé

The SLENDER Integrated Delivery System (IDS™) is an 'all-in-one' fixed-wire coronary stenting device designed for direct stenting, precluding the need for conventional guidewires and predilatation balloons. It achieves ultra-low profiles (crossing profiles as low as 0.029″/0.737 mm), enabling the downsizing of catheters to facilitate transradial intervention in a large subsets of patients. The IDS represents the first advance in coronary stent delivery since the introduction of rapid-exchange stent delivery systems >20 years ago. SLENDER IDS has demonstrated non-inferiority compared with commercial DES, excellent long-term safety and a potentially more efficient approach to PCI where patient comfort is enhanced, procedures are streamlined, and resource consumption is reduced. This paper will summarize the novel features of this new stent delivery system and the early clinical data demonstrating safety and efficacy.

Identifiants

pubmed: 31101587
pii: S1553-8389(19)30240-4
doi: 10.1016/j.carrev.2019.04.014
pii:
doi:

Substances chimiques

Cardiovascular Agents 0
Sirolimus W36ZG6FT64

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

205-212

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Tim A Fischell (TA)

Borgess Heart Institute and Western Michigan University, Kalamazoo, MI, USA. Electronic address: tafisc@gmail.com.

Abilash Balmuri (A)

Borgess Heart Institute and Western Michigan University, Kalamazoo, MI, USA.

Sourabh Agarwal (S)

Borgess Heart Institute and Western Michigan University, Kalamazoo, MI, USA.

Stefan Verhye (S)

Antwerp Cardiovascular Center, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH